Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (51-60 of 304) with videos related to

Pageof 31
Sort By:
Mabs|May 30, 2025
Does one model fit all mAbs? An evaluation of population pharmacokinetic modelsStefan P H van den Berg, Philine E A Adolfsen, Thomas P C Dorlo, et al.
Annals of the Rheumatic Diseases|September 8, 2021
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancyNafise Ghalandari, Erik Kemper, Ineke Hubertina Crijns, et al.
Mabs|September 5, 2020
Biased anti-idiotype response in rabbits leads to high-affinity monoclonal antibodies to biologicsChristina Großerichter-Wagener, Dorien Kos, Astrid van Leeuwen, et al.
Bioanalysis|June 5, 2018
Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra<sup>®</sup> microsampler vs dried blood spotKarien Bloem, Tiny Schaap, Ronald Boshuizen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2019
Infusion-related events during natalizumab: No need for post-infusion monitoringFloor C Loonstra, Johannis A van Rossum, Zoé LE van Kempen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactionsTheo Rispens, Pleuni Ooievaar-De Heer, Ellen Vermeulen, et al.
RMD Open|August 20, 2024
Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at riskNienke Oskam, Pleuni Ooijevaar-de Heer, Dorien Kos, et al.
Journal of Immunological Methods|October 12, 2011
Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testingTheo Rispens, Henk de Vrieze, Els de Groot, et al.
Analytical Biochemistry|January 11, 2011
Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibodyTheo Rispens, Astrid van Leeuwen, Anke Vennegoor, et al.
Frontiers in Immunology|July 18, 2022
Optimized Protocols for <i>In-Vitro</i> T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited CellsCasper Marsman, Dorit Verhoeven, Jana Koers, et al.
Pageof 31

Showing results (51-60 of 304) with videos related to

Sort By:
Pageof 31
Mabs|May 30, 2025
Does one model fit all mAbs? An evaluation of population pharmacokinetic modelsStefan P H van den Berg, Philine E A Adolfsen, Thomas P C Dorlo, et al.
Annals of the Rheumatic Diseases|September 8, 2021
Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancyNafise Ghalandari, Erik Kemper, Ineke Hubertina Crijns, et al.
Mabs|September 5, 2020
Biased anti-idiotype response in rabbits leads to high-affinity monoclonal antibodies to biologicsChristina Großerichter-Wagener, Dorien Kos, Astrid van Leeuwen, et al.
Bioanalysis|June 5, 2018
Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra<sup>®</sup> microsampler vs dried blood spotKarien Bloem, Tiny Schaap, Ronald Boshuizen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 26, 2019
Infusion-related events during natalizumab: No need for post-infusion monitoringFloor C Loonstra, Johannis A van Rossum, Zoé LE van Kempen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactionsTheo Rispens, Pleuni Ooievaar-De Heer, Ellen Vermeulen, et al.
RMD Open|August 20, 2024
Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at riskNienke Oskam, Pleuni Ooijevaar-de Heer, Dorien Kos, et al.
Journal of Immunological Methods|October 12, 2011
Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testingTheo Rispens, Henk de Vrieze, Els de Groot, et al.
Analytical Biochemistry|January 11, 2011
Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibodyTheo Rispens, Astrid van Leeuwen, Anke Vennegoor, et al.
Frontiers in Immunology|July 18, 2022
Optimized Protocols for <i>In-Vitro</i> T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited CellsCasper Marsman, Dorit Verhoeven, Jana Koers, et al.
Pageof 31